Mohammad Reza Hajinezhad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mohammad Reza Hajinezhad has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Abbas Rahdar
Department of Physics, University of Zabol, Zabol, Iran
3 shared publications - Faezeh Askari
Department of Physics, University of Zabol, Zabol, Islamic Republic of Iran
2 shared publications - George Z. Kyzas
Democritus University of Thrace
2 shared publications - Mehdi Noura
Department of Physics, University of Zabol, Zabol, Islamic Republic of Iran
2 shared publications - Saman Sargazi
Cellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan 9816743463, Iran
2 shared publications - Vishnu Sankar Sivasankarapillai
Department of Chemistry, NSS Hindu College, Changanacherry, India
2 shared publications
Latest Publications
- 18 June 2022
- Published by Springer Nature in Medical Oncology
- Vol. 39 (9) , 1-14
Effects of folate-conjugated Fe2O3@Au core–shell nanoparticles on oxidative stress markers, DNA damage, and histopathological characteristics: evidence from in vitro and in vivo studies
The aim of this work was to assess the cytotoxicity, genotoxicity, and histopathological effects of Fe2O3@Au-FA NPs using in vitro and in vivo models. Cytotoxicity and cellular uptake of nanoparticles (NPs) by HUVECs were examined via 3‐(4, 5‐Dimethylthiazol‐2‐yl)‐2, 5‐diphenyltetrazolium bromide (MTT) assay and inductively coupled plasma-mass-spectrometry (ICP-MS). This safe dose was then used for cytotoxicity assays, including total protein, total antioxidant capacity, lipid peroxidation, cell membrane integrity, reactive oxygen species, enzyme activity, and DNA damage. In the animal model, 32 Wistar rats were randomly categorized into 4 groups and received intraperitoneal injections of NPs. Blood samples for biochemical properties and histopathological changes were investigated. MTT results indicated 20 μg/ml as the safe dose for NPs. According to ICP-MS, treated cells showed significantly higher levels of the intracellular content of Fe (p < 0.001) and Au (p < 0.01) compared with the control group. In vitro tests did not show any significant cytotoxicity or genotoxicity at the safe dose of NPs. We found no significant elevation in intracellular γ-H2AX levels after treatment of HUVEC cells with Fe2O3@Au core–shell NPs (P > 0.05). As for the in vivo analysis, we observed no marked difference in serum biochemical parameters of rats treated with 50 mg/kg and 100 mg/kg doses of our NPs. Histopathological assessments indicated that liver, kidney, and testis tissues were not significantly affected at 50 mg/kg (liver), 50 mg/kg, and 100 mg/kg (kidney and testis) on NPs administration. These findings imply that the nanotoxicity of Fe2O3@Au-FA NPs in HUVECs and animals depends largely on the administrated dose. Our study suggests that Fe2O3@Au-FA NPs at a safe dose could be considered as new candidates in nanobiomedicine.
- 18 June 2022
- Published by Springer Nature in Medical Oncology
- Vol. 39 (9) , 1-14
Effects of folate-conjugated Fe2O3@Au core–shell nanoparticles on oxidative stress markers, DNA damage, and histopathological characteristics: evidence from in vitro and in vivo studies
The aim of this work was to assess the cytotoxicity, genotoxicity, and histopathological effects of Fe2O3@Au-FA NPs using in vitro and in vivo models. Cytotoxicity and cellular uptake of nanoparticles (NPs) by HUVECs were examined via 3‐(4, 5‐Dimethylthiazol‐2‐yl)‐2, 5‐diphenyltetrazolium bromide (MTT) assay and inductively coupled plasma-mass-spectrometry (ICP-MS). This safe dose was then used for cytotoxicity assays, including total protein, total antioxidant capacity, lipid peroxidation, cell membrane integrity, reactive oxygen species, enzyme activity, and DNA damage. In the animal model, 32 Wistar rats were randomly categorized into 4 groups and received intraperitoneal injections of NPs. Blood samples for biochemical properties and histopathological changes were investigated. MTT results indicated 20 μg/ml as the safe dose for NPs. According to ICP-MS, treated cells showed significantly higher levels of the intracellular content of Fe (p < 0.001) and Au (p < 0.01) compared with the control group. In vitro tests did not show any significant cytotoxicity or genotoxicity at the safe dose of NPs. We found no significant elevation in intracellular γ-H2AX levels after treatment of HUVEC cells with Fe2O3@Au core–shell NPs (P > 0.05). As for the in vivo analysis, we observed no marked difference in serum biochemical parameters of rats treated with 50 mg/kg and 100 mg/kg doses of our NPs. Histopathological assessments indicated that liver, kidney, and testis tissues were not significantly affected at 50 mg/kg (liver), 50 mg/kg, and 100 mg/kg (kidney and testis) on NPs administration. These findings imply that the nanotoxicity of Fe2O3@Au-FA NPs in HUVECs and animals depends largely on the administrated dose. Our study suggests that Fe2O3@Au-FA NPs at a safe dose could be considered as new candidates in nanobiomedicine.
- Open Access
Assessment of SnFe2O4 Nanoparticles for Potential Application in Theranostics: Synthesis, Characterization, In Vitro, and In Vivo Toxicity
In this research, tin ferrite (SnFe2O4) NPs were synthesized via hydrothermal route using ferric chloride and tin chloride as precursors and were then characterized in terms of morphology and structure using Fourier-transform infrared spectroscopy (FTIR), Ultraviolet–visible spectroscopy (UV-Vis), X-ray power diffraction (XRD), Scanning electron microscopy (SEM), Transmission electron microscopy (TEM), and Brunauer–Emmett–Teller (BET) method. The obtained UV-Vis spectra was used to measure band gap energy of as-prepared SnFe2O4 NPs. XRD confirmed the spinel structure of NPs, while SEM and TEM analyses disclosed the size of NPs in the range of 15–50 nm and revealed the spherical shape of NPs. Moreover, energy dispersive X-ray spectroscopy (EDS) and BET analysis was carried out to estimate elemental composition and specific surface area, respectively. In vitro cytotoxicity of the synthesized NPs were studied on normal (HUVEC, HEK293) and cancerous (A549) human cell lines. HUVEC cells were resistant to SnFe2O4 NPs; while a significant decrease in the viability of HEK293 cells was observed when treated with higher concentrations of SnFe2O4 NPs. Furthermore, SnFe2O4 NPs induced dramatic cytotoxicity against A549 cells. For in vivo study, rats received SnFe2O4 NPs at dosages of 0, 0.1, 1, and 10 mg/kg. The 10 mg/kg dose increased serum blood urea nitrogen and creatinine compared to the controls (P < 0.05). The pathology showed necrosis in the liver, heart, and lungs, and the greatest damages were related to the kidneys. Overall, the in vivo and in vitro experiments showed that SnFe2O4 NPs at high doses had toxic effects on lung, liver and kidney cells without inducing toxicity to HUVECs. Further studies are warranted to fully elucidate the side effects of SnFe2O4 NPs for their application in theranostics.
Open AccessAssessment of SnFe2O4 Nanoparticles for Potential Application in Theranostics: Synthesis, Characterization, In Vitro, and In Vivo Toxicity
In this research, tin ferrite (SnFe2O4) NPs were synthesized via hydrothermal route using ferric chloride and tin chloride as precursors and were then characterized in terms of morphology and structure using Fourier-transform infrared spectroscopy (FTIR), Ultraviolet–visible spectroscopy (UV-Vis), X-ray power diffraction (XRD), Scanning electron microscopy (SEM), Transmission electron microscopy (TEM), and Brunauer–Emmett–Teller (BET) method. The obtained UV-Vis spectra was used to measure band gap energy of as-prepared SnFe2O4 NPs. XRD confirmed the spinel structure of NPs, while SEM and TEM analyses disclosed the size of NPs in the range of 15–50 nm and revealed the spherical shape of NPs. Moreover, energy dispersive X-ray spectroscopy (EDS) and BET analysis was carried out to estimate elemental composition and specific surface area, respectively. In vitro cytotoxicity of the synthesized NPs were studied on normal (HUVEC, HEK293) and cancerous (A549) human cell lines. HUVEC cells were resistant to SnFe2O4 NPs; while a significant decrease in the viability of HEK293 cells was observed when treated with higher concentrations of SnFe2O4 NPs. Furthermore, SnFe2O4 NPs induced dramatic cytotoxicity against A549 cells. For in vivo study, rats received SnFe2O4 NPs at dosages of 0, 0.1, 1, and 10 mg/kg. The 10 mg/kg dose increased serum blood urea nitrogen and creatinine compared to the controls (P < 0.05). The pathology showed necrosis in the liver, heart, and lungs, and the greatest damages were related to the kidneys. Overall, the in vivo and in vitro experiments showed that SnFe2O4 NPs at high doses had toxic effects on lung, liver and kidney cells without inducing toxicity to HUVECs. Further studies are warranted to fully elucidate the side effects of SnFe2O4 NPs for their application in theranostics.
- Open Access
- 15 May 2020
- Published by Springer Nature in Applied Physics A
- Vol. 126 (6) , 1
Correction to: Synthesis, characterization, and intraperitoneal biochemical studies of zinc oxide nanoparticles in Rattus norvegicus
- 15 May 2020
- Published by Springer Nature in Applied Physics A
- Vol. 126 (6) , 1
Open AccessCorrection to: Synthesis, characterization, and intraperitoneal biochemical studies of zinc oxide nanoparticles in Rattus norvegicus
- 18 April 2020
- Published by Springer Nature in Applied Physics A
- Vol. 126 (5) , 1-9
Synthesis, characterization, and intraperitoneal biochemical studies of zinc oxide nanoparticles in Rattus norvegicus
- 18 April 2020
- Published by Springer Nature in Applied Physics A
- Vol. 126 (5) , 1-9
Synthesis, characterization, and intraperitoneal biochemical studies of zinc oxide nanoparticles in Rattus norvegicus
- Open Access
- 31 July 2016
- Published by Brieflands in Zahedan Journal of Research in Medical Sciences
- Vol. 18 (8)
Possible Involvement of Beta-Adrenergic Receptors on Nociceptin/Orphanin FQ Induced Food Consumption in Male Rats
Background: The nociceptin/orphanin FQ (N/OFQ) peptide is the endogenous ligand for the N/OFQ peptide (NOP) receptor. Beta adrenergic receptors and N/OFQ are involved in the regulation of food intake through central and peripheral mechanisms. Objectives: The aim of this study was to determine the possible interaction between beta adrenergic and N/OFQ receptors on food consumption in male rats. N/OFQ agonists have been shown to increase food intake in mammals and birds. Beta adrenergic receptors physiologically inhibit food intake in mammals. Methods: In this experimental study were used male rats (250-300 g). In first two experiments, rats received intraperitoneal injections of isoproterenol (0, 0.5, 1 and 2 mg/kg) and Nociceptin agonist 64 - 6198 (0, 1, 2 and 4 mg/kg) respectively. In third experiment 64 - 6198 (4 mg/kg) and (2 mg/kg) isoproterenol were injected. In experiments 4 effects of isoproterenol (0.5 mg/kg) and Nociceptin antagonist (8 mg/kg) on food consumption was investigated. Latency time to feeding was examined in experiment 5. The data were statistically analyzed using One-way ANOVA and Tukey test. Results: Latency time to feeding increased and decreased by isoproterenol and nociceptin/orphanin, respectively. Administration of N/OFQ increased cumulative food intake in rats (P < 0.05). The i.p. injection of isoproterenol decreased food intake and also the hyperphagic effect of N/OFQ agonist is inhibited by isoproterenol, whereas sub-anorectic doses of isoproterenol and N/OFQ antagonist synergistically attenuated cumulative feed consumption when combined (P < 0.01). Conclusions: On the basis of these findings, it can be concluded that isoproterenol may decrease food intake in rats by reduction in the N/OFQ content. Keywords: Food intake; Isoproterenol; Nociceptin/Orphanin FQ’ Rat
- 31 July 2016
- Published by Brieflands in Zahedan Journal of Research in Medical Sciences
- Vol. 18 (8)
Open AccessPossible Involvement of Beta-Adrenergic Receptors on Nociceptin/Orphanin FQ Induced Food Consumption in Male Rats
Background: The nociceptin/orphanin FQ (N/OFQ) peptide is the endogenous ligand for the N/OFQ peptide (NOP) receptor. Beta adrenergic receptors and N/OFQ are involved in the regulation of food intake through central and peripheral mechanisms. Objectives: The aim of this study was to determine the possible interaction between beta adrenergic and N/OFQ receptors on food consumption in male rats. N/OFQ agonists have been shown to increase food intake in mammals and birds. Beta adrenergic receptors physiologically inhibit food intake in mammals. Methods: In this experimental study were used male rats (250-300 g). In first two experiments, rats received intraperitoneal injections of isoproterenol (0, 0.5, 1 and 2 mg/kg) and Nociceptin agonist 64 - 6198 (0, 1, 2 and 4 mg/kg) respectively. In third experiment 64 - 6198 (4 mg/kg) and (2 mg/kg) isoproterenol were injected. In experiments 4 effects of isoproterenol (0.5 mg/kg) and Nociceptin antagonist (8 mg/kg) on food consumption was investigated. Latency time to feeding was examined in experiment 5. The data were statistically analyzed using One-way ANOVA and Tukey test. Results: Latency time to feeding increased and decreased by isoproterenol and nociceptin/orphanin, respectively. Administration of N/OFQ increased cumulative food intake in rats (P < 0.05). The i.p. injection of isoproterenol decreased food intake and also the hyperphagic effect of N/OFQ agonist is inhibited by isoproterenol, whereas sub-anorectic doses of isoproterenol and N/OFQ antagonist synergistically attenuated cumulative feed consumption when combined (P < 0.01). Conclusions: On the basis of these findings, it can be concluded that isoproterenol may decrease food intake in rats by reduction in the N/OFQ content. Keywords: Food intake; Isoproterenol; Nociceptin/Orphanin FQ’ Rat
- Open Access
- 1 April 2015
- Published by CASRP: Center of Advanced Scientific Research and Publications in Internal Medicine Today
- Vol. 21 (1) , 31-36
Effect of Hydroalcoholic Extract of Prosopis farcta Pod on Liver Histopathology and Malondialdehyde Level in Streptozotocin Diabetic Rats
Medical journal of gonabad university. ofoghedanesh ofogh-e-danesh
- 1 April 2015
- Published by CASRP: Center of Advanced Scientific Research and Publications in Internal Medicine Today
- Vol. 21 (1) , 31-36
Open AccessEffect of Hydroalcoholic Extract of Prosopis farcta Pod on Liver Histopathology and Malondialdehyde Level in Streptozotocin Diabetic Rats
Medical journal of gonabad university. ofoghedanesh ofogh-e-danesh